🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (December 15, 2012) – Revue de presse (15 décembre 2012)

When Fighting Cancer Isn't Worth It
The most aggressive treatments currently available don't guarantee
success, and they aren't right for everyone.
By Mary Mulcahy. In The Atlantic
http://www.theatlantic.com/health/archive/2012/12/when-fighting-cancer-isnt-worth-it/266180/

In challenge to personalized cancer care, DNA isn't all-powerful
The cancer cells were not behaving the way the textbooks say they
should. Some of the cells in colonies that were started with
colorectal tumor cells were propagating like mad; others were hardly
multiplying. Some were dropping dead from chemotherapy and others were
no more slowed by the drug than is a tsunami by a tissue. Yet the
cells in each "clone" all had identical genomes, supposedly the all-
powerful determinant of how cancer cells behave.
By Sharon Begley. In Reuters
http://www.reuters.com/article/2012/12/13/us-science-cancer-dna-idUSBRE8BC19620121213

'Two-faced' cells discovered in colon cancer
Immune cells can suppress or promote tumor growth.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/nu-cd121312.php

Cancer stem cells isolated from kidney tumors
Scientists have isolated cancer stem cells that lead to the growth of
Wilms' tumours, a type of cancer typically found in the kidneys of
young children. The researchers have used these cancer stem cells to
test a new therapeutic approach that one day might be used to treat
some of the more aggressive types of this disease. The results are
published online in EMBO Molecular Medicine.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/embo-csc121112.php

Researchers find new culprit in castration-resistant prostate cancer
Previously unknown protein function could be a treatment target.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/dci-rfn121312.php

New technique for minimally invasive robotic kidney cancer surgery
Urologists at Henry Ford Hospital have developed a new technique that
could make minimally invasive robotic partial nephrectomy procedures
the norm, rather than the exception for kidney cancer patients. The
technique spares the kidney, eliminates long hospital stays and
provides better outcomes by giving the surgeon more time to perform
the procedure.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2012-12/hfhs-nt121312.php



Aspirin could be prescribed to cut cancer cases
Aspirin could be prescribed to patients at risk of developing cancer
as part of new measures to combat the disease, the Department of
Health has disclosed.
By Tom Rowleyraph.co.uk
http://www.telegraph.co.uk/health/healthnews/9740127/Aspirin-could-be-prescribed-to-cut-cancer-cases.html

Rembrandt's Bathsheba did not have breast cancer after all: cientists
cast new light on famous painting
In 1654, Rembrandt van Rijn painted his famous Bathsheba, which
depicts King David's wife naked at her bath. The painting has been
regarded as an icon for breast cancer since the 1980s, after two
Australian surgeons had interpreted the blue mark on her breast as
breast cancer and wrote an article about it. Now, with the help of
computer simulations, researchers from the MIRA research institute at
the University of Twente have demonstrated that it is 'highly
unlikely' that the blue mark on Bathsheba's breast really was caused
by the disease.
In Phys Org
http://phys.org/news/2012-12-rembrandt-bathsheba-breast-cancer-scientists.html

Substance With Promising in Vitro Anti-Cancer Effects Synthesized:
Substance Found in Tiny Amounts in Chinese Medicinal Herb
In science's equivalent of ascending Mt. Everest, researchers are
reporting success in one of the most difficult challenges in synthetic
chemistry -- a field in which scientists reproduce natural and other
substances from jars of chemicals in a lab.
In Science Daily (press release)
http://www.sciencedaily.com/releases/2012/12/121212130938.htm


Cancer : une fillette en rémission grâce au sida
Une thérapie génique encore expérimentale a permis à Emma Whitehead,
qui souffrait d'une leucémie avancée, de connaître un spectaculaire
rétablissement.
Dans Le Nouvel Observateur
http://tempsreel.nouvelobs.com/societe/20121211.OBS2159/cancer-une-fillette-en-remission-grace-au-sida.html

ÉTUDE. Le café limiterait les risques de mortalité de certains cancers
Boire plus de quatre tasses de café par jour pourrait diminuer de
moitié le risque de décès du cancer oro-pharyngé (relatif à la bouche
et au pharynx), selon une étude menée par l'American Cancer Society,
publiée dans le dernier numéro du American Journal of Epidemiology.
Par Stanislas Wang-Genh. Dans Le Huffington Post
http://www.huffingtonpost.fr/2012/12/11/cafe-limiterait-risque-mortalite-malades-cancer-bouche-pharynx-etude_n_2277341.html?utm_hp_ref=france

Cancer du sein : certaines femmes recevront 10 ans de tamoxifène au
lieu de 5
L'allongement de la durée du traitement par tamoxifène en adjuvant à
10 ans permet de réduire le risque de récidive tardive du cancer du
sein avec expression des récepteurs aux estrogènes (ER+) et améliore
la survie, selon l'étude ATLAS (Adjuvant Tamoxifen - Longer Against
Shorter) présentée au San Antonio Breast Cancer Symposium (SABCS) et
publiée simultanément dans le Lancet.
Par Aude Lecrubier. Dans Medscape-France
http://www.medscape.fr/oncologie/articles/1485201/

Cancer du col: faire un frottis après test HPV positif est gagnant
Selon une étude prospective finlandaise , le dépistage du cancer du
col de l'utérus par la recherche de l'ADN du papillomavirus humain
(HPV), couplée à un examen cytologique par frottis cervico-utérin en
cas de résultat positif, permet de détecter davantage de lésions
précancéreuses, comparativement au frottis seul.
Par Vincent Richeux. Dans Medscape-France
http://www.medscape.fr/oncologie/articles/1485231/

Cancer de la vessie : le tabagisme, premier facteur de risque
Le cancer de la vessie prend de plus en plus d’ampleur en Algérie.
Contrairement à l’Europe, les tumeurs de la vessie constituent au
Maghreb le premier cancer urologique après celui de la prostate.
Par Djamila Kourta. Dans El Watan
http://www.elwatan.com/hebdo/sante/cancer-de-la-vessie-le-tabagisme-premier-facteur-de-risque-09-12-2012-195166_156.php










Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com













Marc Lacroix-Corman – InTextoResearch – Baelen  (12/2012)